Patents by Inventor Juan Oliver

Juan Oliver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110065104
    Abstract: The present invention relates to rapid assays for neuro-humoral factors modulated in response to cardiovascular stress and integration of data obtained from such assays to provide profiles of response to cardiovascular stress that can guide therapy.
    Type: Application
    Filed: April 22, 2010
    Publication date: March 17, 2011
    Inventors: Donald W. Landry, Juan Oliver, Milan N. Stojanovic
  • Publication number: 20090004663
    Abstract: The present invention relates to rapid assays for neuro-humoral factors modulated in response to cardiovascular stress and integration of data obtained from such assays to provide profiles of response to cardiovascular stress that can guide therapy.
    Type: Application
    Filed: June 23, 2008
    Publication date: January 1, 2009
    Inventors: Donald W. Landry, Juan Oliver, Milan N. Stojanovic
  • Publication number: 20070213259
    Abstract: The present invention provides a method for regulating blood pressure in a hemodialysis subject using a vasopressin receptor agonist, so as to facilitate removal of excessive extracellular fluid in the subject.
    Type: Application
    Filed: February 26, 2007
    Publication date: September 13, 2007
    Inventors: Donald Landry, Juan Oliver
  • Patent number: 7183255
    Abstract: The present invention provides a method for regulating blood pressure in a hemodialysis subject using a vasopressin receptor agonist, so as to facilitate removal of excessive extracellular fluid in the subject.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: February 27, 2007
    Assignee: Intradialytic Pharmaceuticals
    Inventors: Donald W. Landry, Juan A. Oliver
  • Patent number: 7022666
    Abstract: This invention provides methods of using a gp130 receptor ligand, e.g. leukemia inhibitory factor, to induce the formation of kidney epithelia, to treat subjects suffering from kidney failure, and to preserve kidneys for transplantation.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: April 4, 2006
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jonathan M. Barasch, Juan A. Oliver, Jun Yang
  • Publication number: 20040229798
    Abstract: The present invention provides a method for regulating blood pressure in a hemodialysis subject using a vasopressin receptor agonist, so as to facilitate removal of excessive extracellular fluid in the subject.
    Type: Application
    Filed: February 26, 2004
    Publication date: November 18, 2004
    Inventors: Donald W. Landry, Juan A. Oliver
  • Patent number: 6423681
    Abstract: This invention provides methods of using a gpl3O receptor ligand, e.g. leukemia inhibitory factor, to induce the formation of kidney epithelia, to treat subjects suffering from kidney failure, and to preserve kidneys for transplantation.
    Type: Grant
    Filed: May 4, 1999
    Date of Patent: July 23, 2002
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jonathan M. Barasch, Juan A. Oliver, Jun Yang